Selank: Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides โ
๐TL;DR
- โข4 community protocols documented
- โขEvidence level: Structured Community Data
- โขBased on 120 community reports
- โข3 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Administration Route | Russian clinical trials used an intranasal spray formulation (Selank 0.15% solution). Approved as an intranasal medication in Russia. | Community primarily uses intranasal spray, closely matching the clinical route. Some users also use subcutaneous injection, which is not studied in clinical settings. | low Selank is unusual among peptides in that the community route (intranasal) closely matches the clinically studied route, lending more confidence to community protocols than most peptides. |
| Dosing Range | Russian clinical studies used doses of 250-300 mcg intranasally per administration, typically 3 times daily (750-900 mcg/day total). | Community doses range from 200-900 mcg/day, with most users starting at lower doses (200-300 mcg/day) and titrating upward based on response. | low Community dosing generally falls within the range used in Russian clinical trials, though some users use lower daily doses than studied. |
| Cycle Duration | Clinical studies typically ran for 14-28 days of continuous administration without specified cycling protocols. | Community widely adopts cycling patterns (commonly 4 weeks on, 4 weeks off or 1 month on, 1 month off), citing concerns about tolerance development and receptor desensitization. | moderate The cycling practice is community-derived. Russian clinical use does not emphasize cycling, but long-term continuous use data is limited. |
Compare these community approaches with published research findings.
Community Protocols
Standard Intranasal Protocol
Popular- Route
- Intranasal
- Dose
- 200-300 mcg
- Frequency
- 2-3 times daily
- Duration
- 4-6 weeks
Most widely used protocol; 2-3 spray pumps per nostril daily, typically cycled 1 month on / 1 month off
Higher-Dose Anxiolytic Protocol
Common- Route
- Intranasal
- Dose
- 600-900 mcg
- Frequency
- 2-3 times daily (split doses)
- Duration
- 2-4 weeks
Used by those seeking stronger anxiolytic effects; total daily dose split across administrations
Subcutaneous Injection Protocol
Common- Route
- Subcutaneous
- Dose
- 250-500 mcg
- Frequency
- Once daily
- Duration
- 4-6 weeks (5 days on, 2 days off)
Some users prefer injection for more consistent dosing; 5-days-on/2-off cycling common
Low-Dose Maintenance
Niche- Route
- Intranasal
- Dose
- 100-200 mcg
- Frequency
- Once daily
- Duration
- Ongoing (4 weeks on, 4 weeks off)
Used as a daily anxiolytic/nootropic maintenance dose with monthly cycling
Stacking Patterns
Selank + Semax Nootropic Stack
PopularThe most popular nootropic peptide stack; Selank provides anxiolytic calming effects while Semax provides cognitive stimulation and focus, producing a state of calm alertness
Selank + NA-Selank Enhanced Stack
CommonSome users alternate between standard Selank and the N-Acetyl (NA-Selank) variant, which is reported to have enhanced stability and potency
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 120+ self-experimenters report. Free with email.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Sources
- Reddit r/Nootropics|Selank experience reports and intranasal protocol discussions(accessed 2026-02-16)
- Reddit r/Peptides|Selank dosing and cycling protocol threads(accessed 2026-02-16)
- PeptideDosages.com|Selank 10mg Vial Dosage Protocol(accessed 2026-02-16)
- Jay Campbell|Selank Anxiety Peptide dosage, nootropic benefits and risks(accessed 2026-02-16)
- Peptides.org|Selank Dosage Calculator and Chart(accessed 2026-02-16)
- Innerbody|Selank Peptide benefits, safety and buying advice(accessed 2026-02-16)
Community Evidence Overview#
This page presents aggregated community protocols and anecdotal reports for Selank. The information below is gathered from peptide research forums, Reddit communities (r/Nootropics, r/Peptides), and self-experimenter reports. This is not clinical evidence and should not be used as medical guidance.
Selank occupies a unique position among community-used peptides because it is actually an approved medication in Russia, prescribed as an intranasal anxiolytic and nootropic. This means community protocols are better grounded in clinical data than most peptides discussed in self-experimenter communities. However, it is not approved by the FDA or EMA, and most community users obtain research-grade material rather than pharmaceutical-grade product.
Understanding Protocol Divergence#
Route of Administration#
Unlike most peptides where community usage diverges significantly from research protocols, Selank community use closely mirrors the clinically studied route. Russian clinical trials used intranasal spray, and this is also the primary route used by the community. Some users opt for subcutaneous injection, but intranasal is overwhelmingly preferred due to convenience, the rapid onset of effects (within minutes), and alignment with the approved formulation.
Dosing and Cycling#
Community dosing of 200-900 mcg/day falls within the range used in Russian clinical studies (750-900 mcg/day in divided doses). However, many community users start at the lower end of this range. The main divergence is in cycling patterns: the community widely practices cycling (4 weeks on, 4 weeks off), which is not emphasized in Russian clinical prescribing but is adopted as a precaution against potential tolerance development.
Commonly Reported Outcomes#
Community members frequently report the following effects from Selank use:
- Onset of effects: Anxiolytic effects often noticed within 1-2 weeks, with cognitive benefits developing over 4-6 weeks of use
- Anxiety reduction: The most commonly reported benefit, described as a calm, clear-headed state without sedation
- Cognitive clarity: Users report improved focus and mental clarity, particularly under stress
- Mood stabilization: Reports of more even emotional responses and reduced irritability
- Sleep quality: Some users report modest improvements in sleep onset, particularly when anxiety was disrupting sleep
Important Caveats#
- Selank is rapidly metabolized and undetectable in blood within 10 minutes of intranasal administration, making pharmacokinetic assessment difficult
- While Selank has more clinical data than most community-used peptides (due to Russian approval), the majority of published research is in Russian-language journals
- Product quality varies significantly between research peptide vendors and pharmaceutical-grade Russian Selank
- Self-reported anxiolytic effects are highly susceptible to placebo response
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Frequently Asked Questions About Selank
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.